Pharming Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	376.13	297.2	245.32	205.62	198.87
Revenue Growth (YoY)	26.56%	21.15%	19.30%	3.40%	-6.27%
Cost of Revenue	45.5	35.4	25.21	17.56	21.14
Gross Profit	330.63	261.8	220.1	188.06	177.73
Selling, General & Admin	202.85	184.43	175.26	127.44	90.97
Research & Development	98.17	83.15	68.66	52.53	65.38
Other Operating Expenses	-2.63	-2.18	-2.07	-2.28	-2.62
Operating Expenses	298.39	265.4	241.85	177.69	153.73
Operating Income	32.24	-3.59	-21.75	10.37	24
Interest Expense	-18.14	-8.74	-5.96	-5.36	-6.09
Interest & Investment Income	2.18	4.86	3.66	0.09	0.05
Earnings From Equity Investments	0.62	-1.76	-0.29	-1.08	0.69
Currency Exchange Gain (Loss)	-	1.99	-2.97	4.4	14.84
Other Non Operating Income (Expenses)	2.35	3.78	-1.06	-1.29	-0.09
EBT Excluding Unusual Items	19.25	-3.47	-28.38	7.12	33.4
Merger & Restructuring Charges	-10.3	-	-	-	-
Gain (Loss) on Sale of Investments	-	-	-	12.24	0.11
Gain (Loss) on Sale of Assets	-	-	21.28	-	-
Asset Writedown	-	-5.03	-4.92	-4.38	-10.44
Other Unusual Items	3.9	-	-	-	-
Pretax Income	12.85	-8.49	-12.01	14.99	23.08
Income Tax Expense	10.31	3.35	-1.46	1.31	7.08
Earnings From Continuing Operations	2.54	-11.84	-10.55	13.67	16
Minority Interest in Earnings	0.31	-	-	-	-
Net Income	2.85	-11.84	-10.55	13.67	16
Net Income to Common	2.85	-11.84	-10.55	13.67	16
Net Income Growth	-	-	-	-14.52%	-57.62%
Shares Outstanding (Basic)	713	671	657	649	642
Shares Outstanding (Diluted)	713	671	657	707	701
Shares Change (YoY)	6.17%	2.18%	-7.09%	0.85%	2.70%
EPS (Basic)	0.00	-0.02	-0.02	0.02	0.02
EPS (Diluted)	0.00	-0.02	-0.02	0.02	0.02
EPS Growth	-	-	-	-17.39%	-58.18%
Free Cash Flow	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Per Share	0.08	-0.00	-0.03	0.03	0.04
Gross Margin	87.90%	88.09%	89.72%	91.46%	89.37%
Operating Margin	8.57%	-1.21%	-8.87%	5.04%	12.07%
Profit Margin	0.76%	-3.98%	-4.30%	6.65%	8.04%
Free Cash Flow Margin	14.35%	-0.87%	-7.64%	10.25%	13.63%
EBITDA	43.46	3.22	-15.29	17.13	30.39
EBITDA Margin	11.55%	1.08%	-6.23%	8.33%	15.28%
D&A For EBITDA	11.22	6.82	6.46	6.76	6.39
EBIT	32.24	-3.59	-21.75	10.37	24
EBIT Margin	8.57%	-1.21%	-8.87%	5.04%	12.07%
Effective Tax Rate	80.25%	-	-	8.76%	30.69%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.